Tuesday, February 1, 2022

As CEO goes, cash woes drive Sio to give Parkinson's program the heave-ho - Fierce Biotech

Sio is returning the rights to the Parkinson's lentiviral gene therapy program, AXO-Lenti-PD, to Oxford Biomedica. Axovant licensed the global rights ...

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

2 muggers captured by RU students on campus - UNB

Rayhanul Ferdous, a student of Genetic Engineering and Biotechnology department who had his phone stolen told UNB: “I was walking on the eas...